Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A

Among challenges of targeted therapies is the activation of alternative pro-survival signaling pathways in cancer cells, resulting in an acquired drug resistance. Cyclooxygenase-2 (COX-2) is overexpressed in bladder cancer cells, making it an attractive molecular target for the detection and treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourn, Jennifer, Pandey, Sony, Uddin, Jashim, Marnett, Lawrence, Cekanova, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718263/
https://www.ncbi.nlm.nih.gov/pubmed/31497247
http://dx.doi.org/10.18632/oncotarget.27125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718263/
https://www.ncbi.nlm.nih.gov/pubmed/31497247
http://dx.doi.org/10.18632/oncotarget.27125

Ejemplares similares